4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-16-088713
$TCRTCIK 0001107421operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:35 PM ET
Size
8.2 KB
Accession
0001209191-16-088713
Insider Transaction Report
Form 4
CANNON JAMES ANTHONY
Director
Transactions
- Tax Payment
Common Stock
2015-12-31$8.31/sh−4,177$34,711→ 300,302 total - Award
Common Stock
2015-12-31+26,661→ 326,963 total - Tax Payment
Common Stock
2015-12-31$8.31/sh−1,462$12,149→ 304,479 total
Footnotes (3)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]Includes 4,817 shares acquired in a pro rata distribution by Intrexon Corporation.
- [F3]26,661 shares vest on 12/31/2016.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:35 PM ET
- Size
- 8.2 KB